2269 CHESTNUT ST, SAN FRANCISCO, CA
Hims & Hers Health, Inc. Enters $350 Million Convertible Notes Agreement
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Announces Strategic Shift for US Weight Loss Business
Reports Fourth Quarter and Full Year 2025 Financial Results
Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform
Other Events
Reports Third Quarter 2025 Financial Results
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Submission Upload
Correspondence
Prospectus filed pursuant to Rule 424(b)(7)